Ganesh Benzoplast Share Price
94.80+0.48 (+0.51%)
+8.65% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Ganesh Benzoplast Share Price
94.80+0.48 (+0.51%)
+8.65% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Ganesh Benzoplast Share Price
94.80+0.48 (+0.51%)
+8.65% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Ganesh Benzoplast Share Price
94.80+0.48 (+0.51%)
+8.65% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Ganesh Benzoplast Share Price
94.80+0.48 (+0.51%)
+8.65% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Ganesh Benzoplast Share Price
94.80+0.48 (+0.51%)
+8.65% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Ganesh Benzoplast Share Price
94.80+0.48 (+0.51%)
+8.65% past 1 Year
News
Sangam India Reports Strong Second Quarter Revenue Growth
Equity
SANGAMIND
Sangam India Reports Strong Second Quarter EBITDA Growth And Margin Expansion
Equity
SANGAMIND
Sangam India Reports Strong Second Quarter Net Profit Growth
Equity
SANGAMIND
Cera Sanitaryware Reports Higher Second Quarter EBITDA Despite Margin Compression
Equity
CERA
Cera Sanitaryware Reports Strong Second Quarter Revenue Growth
Equity
CERA
Cera Sanitaryware Reports Marginal Year On Year Decline In Second Quarter Profit
Equity
CERA
Zydus Lifesciences Reports Lower EBITDA Margin Despite Yearly EBITDA Growth
Equity
ZYDUSLIFE
Zydus Lifesciences Reports Strong Second Quarter Revenue Growth
Equity
ZYDUSLIFE
Zydus Lifesciences Q2 Net Profit Falls Despite Beating Street Estimate
Equity
ZYDUSLIFE
Ecoreco Reports Stronger Second Quarter EBITDA And Margin Growth
Equity
ECORECO
Ecoreco Reports Stronger Second Quarter Revenue and Net Profit Growth
Equity
ECORECO
Vijaya Diagnostic Raises FY27 EBITDA Margin Guidance To 42 Percent
Equity
VIJAYA
BASF India Reports Strong Second Quarter Revenue Growth
Equity
BASF
BASF India Reports Sharp Year On Year EBITDA Decline In Second Quarter
Equity
BASF
BASF India Reports Sharp Year On Year Decline In Second Quarter Net Profit
Equity
BASF
Prince Pipes Confirms Double Digit Growth And Operating Margin Outlook
Equity
PRINCEPIPE
Aarti Drugs Cuts FY27 Volume Growth Guidance Amid Rising API Prices
Equity
AARTIDRUGS
Vincofe Reports Stronger Second Quarter EBITDA Growth And Margin Expansion
Equity
VINCOFE
Vincofe Reports Strong Second Quarter Revenue Growth Year On Year
Equity
VINCOFE
Vincofe Q2 Consolidated Net Profit Rises 57.9 Percent Year On Year
Equity
VINCOFE